"The Cone Health Cancer Center at MedCenter Mebane offers comprehensive, leading-edge services in the area of cancer care for residents in eastern Alamance County and western Orange County."

During the past decade, Cone Heath Cancer Center at Mebane conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 26 clinical trials were completed, i.e. on average, 65% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 25 clinical trials were completed. i.e. 277.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cone Heath Cancer Center at Mebane" #1 sponsor was "National Cancer Institute (NCI)" with 20 trials, followed by "SWOG Cancer Research Network" with 16 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "GOG Foundation" with 4 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cone Heath Cancer Center at Mebane" #1 collaborator was "National Cancer Institute (NCI)" with 33 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Cone Heath Cancer Center at Mebane" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Invasive Breast Carcinoma" (4 trials), "Ovarian Seromucinous Carcinoma" (4 trials) and "Recurrent Fallopian Tube Carcinoma" (4 trials). Many other conditions were trialed in "Cone Heath Cancer Center at Mebane" in a lesser frequency.

Most popular intervention types in "Cone Heath Cancer Center at Mebane" are "Drug" (42 trials), "Other" (34 trials), "Biological" (22 trials), "Procedure" (10 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Quality-of-Life Assessment" (16 trials), "Docetaxel" (10 trials), "Carboplatin" (7 trials) and "Paclitaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "Cone Heath Cancer Center at Mebane" are 38 trials for "All" genders and 15 trials for "Female" genders.

Currently, there are NaN active trials in "Cone Heath Cancer Center at Mebane". undefined are not yet recruiting, 10 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Cone Heath Cancer Center at Mebane, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Cone Heath Cancer Center at Mebane, 2 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".